Advertisement
-
1.
Warkentin, TE, A Greinacher, A Koster, et al. :Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). .Chest 133::340S. ,2008. .
-
2.
Martel, N, J Lee, and PS Wells. :Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. .Blood 106::2710. ,2005. .
-
3.
Warkentin, TE, MN Levine, J Hirsh, et al. :Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. .N Engl J Med 332::1330. ,1995. .
-
4.
Harbrecht, U, B Bastians, A Kredteck, et al. :Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin. .Neurology 62::657. ,2004. .
-
5.
Girolami, B, P Prandoni, PM Stefani, et al. :The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. .Blood 101::2955. ,2003. .
-
6.
Morris, TA, S Castrejon, G Devendra, et al. :No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. .Chest 132::1131. ,2007. .
-
7.
Warkentin, TE, JA Sheppard, CS Sigouin, et al. :Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. .Blood 108::2937. ,2006. .
-
8.
Warkentin, TE, CP Hayward, LH Boshkov, et al. :Sera from platelets with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. .Blood 84::3691. ,1994. .
-
9.
Warkentin, TE and JG Kelton. :A 14-year study of heparin-induced thrombocytopenia. .Am J Med 101::502. ,1996. .
-
10.
Scott, JR, MB Klein, T Gernsheimer, et al. :Arterial and venous complications of heparin-induced thrombocytopenia in burn patients. .J Burn Care Res 28::71. ,2007. .
-
11.
Warkentin, TE and JG Kelton. :Temporal aspects of heparin-induced thrombocytopenia. .N Engl J Med 344::1286. ,2001. .
-
12.
Greinacher, A, J Amiral, V Dummel, et al. :Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/ heparin enzyme-linked immunosorbent assay. .Transfusion 34::381. ,1994. .
-
13.
Alving, BM . :How I treat heparin-induced thrombocytopenia and thrombosis. .Blood 101::31. ,2003. .
-
14.
Coutre, S . :Heparin-induced thrombocytopenia: Up-to-date online version 18.2 .Available at: www.uptodate.com. .Accessed July 1, 2010.
Heparin-induced Thrombocytopenia in the Setting of Perioperative Bridging for Podiatric Surgery
A Case Report
Heparin is an anticoagulant commonly used to treat and prevent deep venous thrombosis. Heparin-induced thrombocytopenia and possible thrombosis are serious complications associated with its use. This can occasionally complicate treatment of patients undergoing podiatric surgery. Heparin-induced thrombocytopenia is often not immediately recognized and is underreported in podiatric medicine literature. The goal of this case report is to highlight the multiple risk factors associated with the development of heparin-induced thrombocytopenia and to aid with early recognition, understanding of pathogenesis, and treatment options. (J Am Podiatr Med Assoc 103(1): 67–72, 2013)
